Recherches liées
Sanofi-Synthelabo actualité Synthelabo Sanofi infos économique SANOFI-AVENTIS Sanofi-Synthélabo recorded Echos Synthélabo Cotation Aventis Boursorama reported LExpansion.com Sanofi-Synthelabo,
Offres d'emploi chez SANOFI SYNTHELABO
Actualités SANOFI SYNTHELABO
Documents SANOFI SYNTHELABO
- Sanofi-Synthelabo. Industrial. IT. Solutions. Success Story. Sanofi initially chose an ABB ... Sanofi-Synthelabo is the seventh largest pharmaceutical laboratory in. Europe, and the ...
http://library.abb.com/GLOBAL/SCOT/SCOT296.nsf/VerityDisplay/0C2A8E55C39DAADBC1256FA30079F65C/$File/3BUS045003R0001_en_Success_Story___Sanofi_Synthelabo.pdf - Sanofi-Synthélabo recorded significant growth in 2001. Sales for the year were 6,488 million euros, up by 8.8% on a reported basis. and by 15.2% on a comparable basis (after taking account of changes in group structure and in exchange
http://en.sanofi-aventis.com/binaries/2001_Fin-Report_San-Synthe_EN_tcm28-19437.pdf - Alfuzosin is a selective a1?adrenergic blocker developed by Sanofi-Synthelabo Inc. ... Spontaneously reported SAEs recorded in the Sanofi-Synthelabo Pharmacovigilance database transmitted by either the health prof
http://www.fda.gov/ohrms/dockets/ac/03/briefing/3956B1_03_Sanofi-synthelabo.doc - granting a preliminary injunction in favor of Sanofi-Synthelabo, Sanofi-Synthelabo, Inc. ... Sanofi-Synthelabo, slip op. at 31-32. The court. determined that nothing existed in the prior art that would
http://ipwatchdog.com/cases/Sanofi-Synthelabo_v_Apotex.PDF - Paris, France ? August 9, 2004 ? Sanofi-Synthelabo (PARIS: SAN, NYSE: SNY) announces that the ... and Sanofi-Synthelabo's offers will be successful. Sanofi-Synthelabo expects that the AMF will announce th
http://en.sanofi-aventis.com/binaries/20040809_acc_provisional_results_of_the_offers_media2_tcm28-14749.pdf